14 May 2025
// PRESS RELEASE
10 Oct 2024
// PRESS RELEASE
10 Oct 2024
// PRESS RELEASE
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
About
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Attending
08-10 September, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #9.1B74
28-30 October, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Attending
08-10 September, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #9.1B74
28-30 October, 2025
https://www.pharmacompass.com/speak-pharma/polpharma-has-invested-over-35mln-euros-in-a-completely-new-facility-to-handle-hpapis
VLOG #PharmaReel
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
https://www.pharmacompass.com/radio-compass-blog/fda-approves-record-eight-biosimilars-in-h1-2024-okays-first-interchangeable-biosimilars-for-eylea
14 May 2025
// PRESS RELEASE
https://polpharma.pl/en/polpharma-group-joins-the-call-to-action-to-finalize-pharmaceutical-reform-and-secure-early-and-sustainable-healthcare-for-european-patients/
10 Oct 2024
// PRESS RELEASE
https://www.api.polpharma.com/articles/polpharmas-hp-api-facility-is-live
10 Oct 2024
// PRESS RELEASE
https://www.api.polpharma.com/articles/rising-prevalence-of-cancer-and-its-impact-on-the-hp-api-market
10 Oct 2024
// PRESS RELEASE
https://www.api.polpharma.com/articles/addressing-nitrosamine-risks-in-pharmaceutical-manufacturing
01 Oct 2024
// PRESS RELEASE
23 Sep 2024
// PRESS RELEASE
https://polpharma.pl/en/polpharma-and-msn-laboratories-announce-strategic-distribution-partnership/
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-30
Pay. Date : 2013-01-15
DMF Number : 10383
Submission : 1993-07-30
Status : Active
Type : II
Certificate Number : R1-CEP 2010-371 - Rev 02
Issue Date : 2020-08-04
Type : Chemical
Substance Number : 454
Status : Valid
Registration Number : 306MF10013
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2024-01-24
Latest Date of Registration :
NDC Package Code : 12658-0359
Start Marketing Date : 1982-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (40kg/40kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2020-10-19
Registration Number : 20201019-210-J-595
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-12-16
Pay. Date : 2014-11-28
DMF Number : 16962
Submission : 2003-11-17
Status : Active
Type : II
Certificate Number : R1-CEP 2003-273 - Rev 04
Issue Date : 2021-05-12
Type : Chemical
Substance Number : 1564
Status : Valid
Registration Number : 220MF10241
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2008-12-04
Latest Date of Registration :
NDC Package Code : 12658-0489
Start Marketing Date : 1999-11-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg. Filing : ASMF, CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-12-16
Pay. Date : 2014-11-28
DMF Number : 11405
Submission : 1995-03-29
Status : Active
Type : II
Certificate Number : CEP 2013-134 - Rev 03
Issue Date : 2024-12-02
Type : Chemical
Substance Number : 1422
Status : Valid
Registration Number : 225MF10101
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2013-05-10
Latest Date of Registration :
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2020-05-12
Registration Number : 20200324-209-J-453(2)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
Available Reg. Filing : ASMF, CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-01-06
Pay. Date : 2014-12-29
DMF Number : 17599
Submission : 2004-08-12
Status : Active
Type : II
Certificate Number : CEP 2004-058 - Rev 06
Issue Date : 2024-04-12
Type : Chemical
Substance Number : 394
Status : Valid
Registration Number : 218MF11020
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2006-12-28
Latest Date of Registration :
NDC Package Code : 12658-0544
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (30kg/30kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Novartis Korea Ltd.
Registration Date : 2021-05-04
Registration Number : 20180611-209-J-86(3)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
Available Reg. Filing : ASMF, CN, CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-12
Pay. Date : 2016-06-21
DMF Number : 25638
Submission : 2011-12-29
Status : Active
Type : II
Certificate Number : R0-CEP 2022-073 - Rev 00
Issue Date : 2023-02-20
Type : Chemical
Substance Number : 2771
Status : Valid
Registration Number : 303MF10116
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2021-07-20
Latest Date of Registration :
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2019-08-02
Registration Number : No. 2417-3-ND(1)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-02-25
Pay. Date : 2014-06-11
DMF Number : 20548
Submission : 2007-05-23
Status : Active
Type : II
Certificate Number : R1-CEP 2010-128 - Rev 02
Issue Date : 2023-02-16
Type : Chemical
Substance Number : 1756
Status : Valid
Registration Number : 228MF10228
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2016-12-14
Latest Date of Registration :
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2021-11-01
Registration Number : 20210611-209-J-1025(1)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19, Pelplinska street, 83-200 Starogard Gdanski, Poland
Available Reg. Filing : ASMF, CN |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-13
Pay. Date : 2012-12-11
DMF Number : 20384
Submission : 2007-03-26
Status : Active
Type : II
Certificate Number : R1-CEP 2013-126 - Rev 02
Issue Date : 2022-05-09
Type : Chemical
Substance Number : 2572
Status : Valid
Registration Number : 222MF10015
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2010-01-07
Latest Date of Registration :
Registrant Name : YuYu Pharmaceutical Co., Ltd.
Registration Date : 2024-11-26
Registration Number : 20100226-121-G-15-07(7)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19, Pelplinska Street., 83-200 Starogard Gdanski, Poland
Available Reg. Filing : ASMF, CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-08-11
Pay. Date : 2016-06-13
DMF Number : 23930
Submission : 2010-06-29
Status : Active
Type : II
Certificate Number : CEP 2013-073 - Rev 04
Issue Date : 2024-11-19
Type : Chemical
Substance Number : 2270
Status : Valid
Registration Number : 225MF10011
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2013-01-30
Latest Date of Registration :
NDC Package Code : 12658-0483
Start Marketing Date : 1998-03-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg. Filing : ASMF, CN, CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-03-07
Pay. Date : 2017-11-15
DMF Number : 24590
Submission : 2011-01-31
Status : Active
Type : II
Certificate Number : CEP 2012-150 - Rev 02
Issue Date : 2023-10-24
Type : Chemical
Substance Number : 2606
Status : Valid
Registration Number : 302MF10011
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2020-01-24
Latest Date of Registration :
NDC Package Code : 12658-0439
Start Marketing Date : 2003-11-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg. Filing : ASMF, CN |
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-15
Pay. Date : 2015-08-21
DMF Number : 25174
Submission : 2011-08-02
Status : Active
Type : II
Certificate Number : CEP 2014-106 - Rev 02
Issue Date : 2024-05-29
Type : Chemical
Substance Number : 2782
Status : Valid
Registration Number : 231MF10080
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2019-04-03
Latest Date of Registration :
NDC Package Code : 12658-0463
Start Marketing Date : 2003-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2018-10-28
Registration Number : 20181028-211-J-269
Manufacturer Name : Zakłady Farmaceutyczne Polpharma SA
Manufacturer Address : ul. Peplińska 19, 83-200 Starogard Gdański, Poland
Available Reg. Filing : ASMF, CN, CA |
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-30
Pay. Date : 2013-01-15
DMF Number : 10383
Submission : 1993-07-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-10
Pay. Date : 2016-12-20
DMF Number : 31166
Submission : 2016-11-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-04-07
Pay. Date : 2016-12-20
DMF Number : 31141
Submission : 2016-11-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-02-20
Pay. Date : 2013-12-19
DMF Number : 23314
Submission : 2009-11-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33204
Submission : 2018-10-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-08
Pay. Date : 2012-12-11
DMF Number : 18014
Submission : 2005-01-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32347
Submission : 2017-12-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-16
Pay. Date : 2015-06-25
DMF Number : 26266
Submission : 2012-07-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17060
Submission : 2003-12-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-19
Pay. Date : 2016-12-07
DMF Number : 20633
Submission : 2007-06-26
Status : Active
Type : II
Certificate Numbers : R1-CEP 2010-371 - Rev 02
Status : Valid
Issue Date : 2020-08-04
Type : Chemical
Substance Number : 454
Certificate Numbers : R1-CEP 2013-230 - Rev 02
Status : Valid
Issue Date : 2023-03-17
Type : Chemical
Substance Number : 2617
Certificate Numbers : R1-CEP 2012-353 - Rev 01
Status : Valid
Issue Date : 2021-01-21
Type : Chemical
Substance Number : 543
Certificate Numbers : CEP 2004-141 - Rev 04
Status : Valid
Issue Date : 2024-12-02
Type : Chemical
Substance Number : 543
Certificate Numbers : R1-CEP 2002-258 - Rev 08
Status : Valid
Issue Date : 2021-10-22
Type : Chemical
Substance Number : 1745
Certificate Numbers : CEP 2013-134 - Rev 03
Status : Valid
Issue Date : 2024-12-02
Type : Chemical
Substance Number : 1422
Certificate Numbers : CEP 2004-058 - Rev 06
Status : Valid
Issue Date : 2024-04-12
Type : Chemical
Substance Number : 394
Certificate Numbers : R0-CEP 2022-073 - Rev 00
Status : Valid
Issue Date : 2023-02-20
Type : Chemical
Substance Number : 2771
Certificate Numbers : R0-CEP 2023-077 - Rev 00
Status : Valid
Issue Date : 2023-06-30
Type : Chemical
Substance Number : 2771
Certificate Numbers : R1-CEP 2010-128 - Rev 02
Status : Valid
Issue Date : 2023-02-16
Type : Chemical
Substance Number : 1756
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 306MF10013
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2024-01-24
Latest Date of Registration : 2024-01-24
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 220MF10241
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2008-12-04
Latest Date of Registration : 2018-01-15
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 230MF10014
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2018-01-30
Latest Date of Registration : 2019-03-19
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 305MF10084
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2023-07-19
Latest Date of Registration : 2023-07-19
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 225MF10101
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2013-05-10
Latest Date of Registration : 2023-07-26
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 218MF11020
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2006-12-28
Latest Date of Registration : 2024-07-11
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 303MF10116
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2021-07-20
Latest Date of Registration : 2025-03-19
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 228MF10228
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2016-12-14
Latest Date of Registration : 2016-12-14
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 225MF10011
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2013-01-30
Latest Date of Registration : 2020-12-23
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registration Number : 222MF10015
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2010-01-07
Latest Date of Registration : 2018-10-01
NDC Package Code : 12658-0359
Start Marketing Date : 1982-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (40kg/40kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0489
Start Marketing Date : 1999-11-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0612
Start Marketing Date : 1999-11-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (2kg/2kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0623
Start Marketing Date : 2002-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0524
Start Marketing Date : 2002-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0614
Start Marketing Date : 2015-10-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0625
Start Marketing Date : 2015-10-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (12kg/12kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0537
Start Marketing Date : 2015-10-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (6kg/6kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0531
Start Marketing Date : 2015-10-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (8kg/8kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12658-0622
Start Marketing Date : 1977-11-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development t...
Details:
RVU120 is a selective, first-in-class dual CDK8/CDK19 kinase inhibitor that has shown signs of clinical activity in treated patients, as well as efficacy in numerous in vitro and in vivo models of hematologic malignancies and solid tumors.
Lead Product(s): RVU120
Therapeutic Area: Oncology Brand Name: RVU120
Study Phase: PreclinicalProduct Type: Other Small Molecule
Sponsor: Ryvu Therapeutics
Deal Size: $1.0 million Upfront Cash: Undisclosed
Deal Type: Agreement June 07, 2023
Lead Product(s) : RVU120
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Ryvu Therapeutics
Deal Size : $1.0 million
Deal Type : Agreement
Ryvu Therapeutics Enters into Two Agreements with Zakłady Farmaceutyczne Polpharma S.A. in the Ar...
Details : RVU120 is a selective, first-in-class dual CDK8/CDK19 kinase inhibitor that has shown signs of clinical activity in treated patients, as well as efficacy in numerous in vitro and in vivo models of hematologic malignancies and solid tumors.
Product Name : RVU120
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
June 07, 2023
Details:
The partnership involves manufacturing of the drug substance of the clinical candidate PKL-021, needed to support the preclinical research program and the production of an investigational medicinal product for the phase one clinical trial.
Lead Product(s): PKL-021
Therapeutic Area: Neurology Brand Name: PKL-021
Study Phase: PreclinicalProduct Type: Other Small Molecule
Sponsor: Pikralida biopharmaceutical
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership July 19, 2022
Lead Product(s) : PKL-021
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Pikralida biopharmaceutical
Deal Size : Undisclosed
Deal Type : Partnership
Polpharma Partners with Pikralida Biopharmaceutical Start-Up
Details : The partnership involves manufacturing of the drug substance of the clinical candidate PKL-021, needed to support the preclinical research program and the production of an investigational medicinal product for the phase one clinical trial.
Product Name : PKL-021
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 19, 2022
CAS Number : 56961-75-2
End Use API : Octenidine Hydrochloride
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and...
CAS Number : 623-05-2
End Use API : Bisoprolol Fumarate
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and...
CAS Number : 67004-64-2
End Use API : Clemastine
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and...
CAS Number : 826-81-3
End Use API : Chlorquinaldol
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and...
N-(p-toluenesulfonyl)-l-glutamic acid
CAS Number : 4816-80-2
End Use API : Levamisole
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and...
2-(2-chloroethyl)-1-methylpyrrolidine hydrochloride
CAS Number : 56824-22-7
End Use API : Azelastine Hydrochloride
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and...
CAS Number : 22719-67-1
End Use API : 4-Hydroxybenzoic Acid
About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and...
Services
API Manufacturing
API & Drug Product Development
Inspections and registrations
ABOUT THIS PAGE
Polpharma is a supplier offers 81 products (APIs, Excipients or Intermediates).
Find a price of Acetazolamide bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Alendronate Sodium bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Etodolac bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Hydrochlorothiazide bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Ibandronate Sodium bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Lamotrigine bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Risedronate Sodium bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Sildenafil Citrate bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Tadalafil bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Vardenafil Hydrochloride bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Zoledronic Acid bulk with DMF, CEP, JDMF offered by Polpharma
Find a price of Aripiprazole bulk with DMF, CEP offered by Polpharma
Find a price of Baclofen bulk with DMF, JDMF offered by Polpharma
Find a price of Carbamazepine bulk with DMF, CEP offered by Polpharma
Find a price of Carvedilol bulk with DMF, CEP offered by Polpharma
Find a price of Dapagliflozin bulk with DMF, JDMF offered by Polpharma
Find a price of Pentoxifylline bulk with DMF, CEP offered by Polpharma
Find a price of Rivaroxaban bulk with DMF, CEP offered by Polpharma
Find a price of Sodium Salicylate bulk with DMF, JDMF offered by Polpharma
Find a price of Ticagrelor bulk with DMF, CEP offered by Polpharma
Find a price of Apixaban bulk with DMF offered by Polpharma
Find a price of Apremilast bulk with DMF offered by Polpharma
Find a price of Aripiprazole bulk with DMF offered by Polpharma
Find a price of Brexpiprazole bulk with DMF offered by Polpharma
Find a price of Carbamazepine bulk with CEP offered by Polpharma
Find a price of Carvedilol Phosphate bulk with DMF offered by Polpharma
Find a price of Dapagliflozin Propanediol Monohydrate bulk with DMF offered by Polpharma
Find a price of Empagliflozin bulk with DMF offered by Polpharma
Find a price of Enzalutamide bulk with DMF offered by Polpharma
Find a price of Ibandronate Sodium bulk with CEP offered by Polpharma
Find a price of Isavuconazonium Sulfate bulk with DMF offered by Polpharma
Find a price of Linagliptin bulk with DMF offered by Polpharma
Find a price of Molsidomine bulk with CEP offered by Polpharma
Find a price of Oxcarbazepine bulk with DMF offered by Polpharma
Find a price of Palbociclib bulk with DMF offered by Polpharma
Find a price of Pimavanserin Tartrate bulk with DMF offered by Polpharma
Find a price of Piracetam bulk with CEP offered by Polpharma
Find a price of Sacubitril-Valsartan bulk with DMF offered by Polpharma
Find a price of Safinamide Methanesulfonate bulk with DMF offered by Polpharma
Find a price of Sildenafil Citrate bulk with CEP offered by Polpharma
Find a price of Sitagliptin Hydrochloride bulk with DMF offered by Polpharma
Find a price of Tolterodine Tartrate bulk with CEP offered by Polpharma
Find a price of Topiramate bulk with DMF offered by Polpharma
Find a price of Trametinib bulk with DMF offered by Polpharma
Find a price of Xylometazoline Hydrochloride bulk with CEP offered by Polpharma
Find a price of Abemaciclib bulk offered by Polpharma
Find a price of Acenocoumarol bulk offered by Polpharma
Find a price of Alendronate Sodium bulk offered by Polpharma
Find a price of Aniracetam bulk offered by Polpharma
Find a price of Antazoline HCl bulk offered by Polpharma
Find a price of Antazoline Mesylate bulk offered by Polpharma
Find a price of Antazoline Sulfate bulk offered by Polpharma
Find a price of Apixaban bulk offered by Polpharma
Find a price of Aripiprazole Lauroxil bulk offered by Polpharma
Find a price of Baclofen bulk offered by Polpharma
Find a price of Baricitinib bulk offered by Polpharma
Find a price of Carbamazepine bulk offered by Polpharma
Find a price of Carvedilol bulk offered by Polpharma
Find a price of Carvedilol Phosphate bulk offered by Polpharma
Find a price of CAS 66376-36-1 bulk offered by Polpharma
Find a price of Clemastine bulk offered by Polpharma
Find a price of Clopamide bulk offered by Polpharma
Find a price of Denotivir bulk offered by Polpharma
Find a price of Elagolix Sodium bulk offered by Polpharma
Find a price of Etodolac bulk offered by Polpharma
Find a price of Gilteritinib Fumarate bulk offered by Polpharma
Find a price of Hydrochlorothiazide bulk offered by Polpharma
Find a price of Lamotrigine bulk offered by Polpharma
Find a price of Nefopam Hydrochloride bulk offered by Polpharma
Find a price of Opipramol Dihydrochloride bulk offered by Polpharma
Find a price of Ozanimod bulk offered by Polpharma
Find a price of Pentoxifylline bulk offered by Polpharma
Find a price of Phenyl Salicylate bulk offered by Polpharma
Find a price of Risdiplam bulk offered by Polpharma
Find a price of Risedronate Sodium bulk offered by Polpharma
Find a price of Rivaroxaban bulk offered by Polpharma
Find a price of Salicylamide bulk offered by Polpharma
Find a price of Ticagrelor bulk offered by Polpharma
Find a price of Topiramate bulk offered by Polpharma
Find a price of Undecylenic acid monoethanolamide bulk offered by Polpharma
Find a price of Vismodegib bulk offered by Polpharma